The PPARα-FGF21 hormone axis contributes to metabolic regulation by the hepatic JNK signaling pathway.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25043817.
- Also identified by DOI 10.1016/j.cmet.2014.06.010 and PMC identifier 4156535.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The cJun NH2-terminal kinase (JNK) stress signaling pathway is implicated in the metabolic response to the consumption of a high-fat diet, including the development of obesity and insulin resistance. These metabolic adaptations involve altered liver function. Here, we demonstrate that hepatic JNK potently represses the nuclear hormone receptor peroxisome proliferator-activated receptor α (PPARα). Therefore, JNK causes decreased expression of PPARα target genes that increase fatty acid oxidation and ketogenesis and promote the development of insulin resistance. We show that the PPARα target gene fibroblast growth factor 21 (Fgf21) plays a key role in this response because disruption of the hepatic PPARα-FGF21 hormone axis suppresses the metabolic effects of JNK deficiency. This analysis identifies the hepatokine FGF21 as a critical mediator of JNK signaling in the liver.
Medical subject headings
- Fibroblast Growth Factors
- Liver
- MAP Kinase Signaling System
- PPAR alpha